Skip to main
  1. Stocks
  2. Establishment Labs Holdings Inc
  3. Forecast
ESTA

ESTA Stock Forecast & Price Target

ESTA Analyst Ratings

Based on 8 analyst ratings
Strong Buy
Strong Buy 63%
Buy 38%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Establishment Labs Hldgs is benefiting from strong execution in Q3, with revenue of $72.0M up 34% y/y, adjusted EBITDA of $6.4M, and its first positive free cash flow quarter, all while gross margin expanded to 70.8% and operating expenses fell to 68.8% of revenue. The U.S. franchise is gaining traction through Motiva and Preservé, with about 2,100 accounts, 85% of Q2 accounts reordered in Q3, and Preservé already contributing roughly 17% of U.S. revenue as more than 400 surgeons were trained. Further upside is supported by international growth, a rising minimally invasive platform expected to exceed $40M, and FDA-driven pipeline catalysts including smaller implant sizes and a breast reconstruction label expansion that could broaden the addressable market and reinforce 2026 guidance of at least $274M.

Bears say

Establishment Labs Hldgs is facing a weak fundamental backdrop as Motiva, its lead implant line, has produced poor sales results and management has not embedded any meaningful recovery assumptions in 2H26 guidance after several quarters of minimal orders from the Middle East and no contribution in 1Q26. The company also continues to struggle with delayed regulatory clearances, intensifying competition from better-capitalized rivals, and supply risk tied to reliance on a single source for medical-grade silicone. These issues are compounded by a delay in achieving profitability targets, which is pressuring its capital position and limiting its ability to attract and retain key executives and sales staff.

ESTA has been analyzed by 8 analysts, with a consensus rating of Strong Buy. 63% of analysts recommend a Strong Buy, 38% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Establishment Labs Holdings Inc and is not a guaranteed prediction by Public.com or investment advice.

ESTA Analyst Forecast & Price Prediction

Get the latest ESTA stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in ESTA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Establishment Labs Holdings Inc (ESTA) Forecast

Analysts have given ESTA a Strong Buy based on their latest research and market trends.

According to 8 analysts, ESTA has a Strong Buy consensus rating as of Nov 18, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $94.38, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $94.38, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Establishment Labs Holdings Inc (ESTA)


ESTA Analyst Forecast & Price Prediction

Get the latest ESTA stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in ESTA

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover ESTA stock data and trends